Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Thomas Michael Heffernan

Affiliations

  • Director at Collegium Pharmaceutical Inc (COLL), 2019-08-13
  • at Akebia Therapeutics Inc. (AKBA), 2019-06-10
  • Director at Trevi Therapeutics Inc. (TRVI), 2019-05-13
  • Director at Keryx Biopharmaceuticals Inc (KERX), 2018-12-13
  • Director at Ocata Therapeutics Inc. (OCAT), 2016-01-04
  • Director at Cornerstone Therapeutics Inc (CRTX), 2014-02-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TRVI $10.00 2,500 Director 6,351 2019-05-09 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
COLL $11.26 25,000 Director 132,069 2019-07-15 Filing
COLL $12.05 2,021 Director 157,069 2019-06-17 Filing
COLL $11.31 22,979 Director 159,090 2019-06-17 Filing
COLL $13.13 6,517 Director 182,069 2019-05-15 Filing
COLL $12.74 18,483 Director 188,586 2019-05-15 Filing